DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

Anti‐epidermal growth factor receptor (EGFR) treatment is an effective option for metastatic colorectal cancer (CRC) treatment. However, there are few reliable biomarkers to predict the clinical response to anti‐EGFR treatment. We investigated the genome‐wide DNA methylation status in metastatic col...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Ouchi, Kota, Takahashi, Shin, Yamada, Yasuhide, Tsuji, Shingo, Tatsuno, Kenji, Takahashi, Hidekazu, Takahashi, Naoki, Takahashi, Masanobu, Shimodaira, Hideki, Aburatani, Hiroyuki, Ishioka, Chikashi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714671/
https://ncbi.nlm.nih.gov/pubmed/26426205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12827
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados